220 related articles for article (PubMed ID: 34626006)
1. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with skin eruptions mimicking acute generalized exanthematous pustulosis.
Goto T; Kogure A; Kuwano Y
J Dermatol; 2022 Jan; 49(1):e16-e17. PubMed ID: 34626006
[No Abstract] [Full Text] [Related]
2. Demographic and laboratory differences seen between acute generalized exanthematous pustulosis and drug reaction with eosinophilia and systemic symptoms: A cross-sectional analysis.
Gallardo MA; Mallela T; Gilkey T; Himed S; Walker TD; Nusbaum KB; Korman A; Trinidad J; Chung C; Kaffenberger BH
J Am Acad Dermatol; 2023 May; 88(5):1142-1145. PubMed ID: 36442643
[No Abstract] [Full Text] [Related]
3. Overlapping acute generalized exanthematous pustulosis drug reaction with eosinophilia and systemic symptoms induced by a second dose of the Moderna COVID-19 vaccine.
Ikeda T; Yokoyama K; Kawakami T
J Dermatol; 2022 Dec; 49(12):e446-e447. PubMed ID: 35906789
[No Abstract] [Full Text] [Related]
4. Allopurinol-induced drug rash with eosinophilia and systemic symptoms mimicking acute generalized exanthematous pustulosis.
Huang YC; Shih PY; Chin SY; Chiang YY
J Dermatol; 2012 Dec; 39(12):1077-8. PubMed ID: 22901319
[No Abstract] [Full Text] [Related]
5. Drug rash with eosinophilia and systemic symptoms syndrome without eosinophilia managed with intravenous immunoglobulin.
Kerkemeyer KLS; Lee S; Lai FYX; Mar A
Intern Med J; 2020 Sep; 50(9):1156-1157. PubMed ID: 32827350
[No Abstract] [Full Text] [Related]
6. Severe acute generalized exanthematous pustulosis (AGEP) induced by miconazole oral gel with overlapping features of drug reaction with eosinophilia and systemic symptoms (DRESS).
Tedbirt B; Viart-Commin MH; Carvalho P; Courville P; Tétart F
Contact Dermatitis; 2021 Jun; 84(6):474-476. PubMed ID: 33382118
[No Abstract] [Full Text] [Related]
7. Epidemiology of severe drug hypersensitivity.
Dodiuk-Gad RP; Laws PM; Shear NH
Semin Cutan Med Surg; 2014 Mar; 33(1):2-9. PubMed ID: 25037253
[TBL] [Abstract][Full Text] [Related]
8. Delayed cutaneous manifestations of drug hypersensitivity.
Bircher AJ; Scherer K
Med Clin North Am; 2010 Jul; 94(4):711-25, x. PubMed ID: 20609859
[TBL] [Abstract][Full Text] [Related]
9. Utility of patch testing for the diagnosis of delayed-type drug hypersensitivity reactions to clindamycin.
Gilissen L; Huygens S; Goossens A; Breynaert C; Schrijvers R
Contact Dermatitis; 2020 Sep; 83(3):237-239. PubMed ID: 32333605
[No Abstract] [Full Text] [Related]
10. Antipsychotic-Induced Drug Rash With Eosinophilia and Systemic Symptoms Syndrome: A Case Report.
Gica Ş; Elmaci ZC; Balaban ÖD; Karamustafalioglu N
Am J Ther; 2021 Mar-Apr 01; 28(2):e253-e254. PubMed ID: 31513024
[No Abstract] [Full Text] [Related]
11. [The major SCAR syndromes].
Piérard GE; Lesuisse M; Piérard-Franchimont C
Rev Med Liege; 2017 Oct; 72(10):444-447. PubMed ID: 29058836
[TBL] [Abstract][Full Text] [Related]
12. [CME. Severe cutaneous drug reaction].
Deuel J; Schaer D; Schmid-Grendelmeier P; Vallelian F
Praxis (Bern 1994); 2014 Oct; 103(21):1231-43. PubMed ID: 25305114
[No Abstract] [Full Text] [Related]
13. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic syndrome followed by transient palmoplantar keratoderma-like eruption.
Nomura T; Nakajima S; Kashiwa A; Matsuyama K; Hirata M; Ueshima C; Kataoka TR; Kabashima K; Matsui M
J Dermatol; 2021 May; 48(5):e207-e209. PubMed ID: 33630361
[No Abstract] [Full Text] [Related]
14. Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Syndrome Probably Related to Cefpodoxime: A Case Report.
Babu T; Panachiyil GM; Sebastian J; Shastry V
J Pharm Pract; 2021 Feb; 34(1):163-165. PubMed ID: 31382812
[TBL] [Abstract][Full Text] [Related]
15. Acute hepatic failure in trimethoprim-induced drug rash with eosinophilia and systemic symptoms (DRESS).
Connolly A; Walsh S; Philippidou M; Salisbury J; Creamer D
Br J Dermatol; 2023 Jul; 189(1):140-141. PubMed ID: 36946217
[No Abstract] [Full Text] [Related]
16. Drug Rash with Eosinophilia and Systemic Symptoms (DRESS Syndrome).
Mendes MFL; Fernandes DS; Brandão I
Acta Medica (Hradec Kralove); 2023; 66(1):28-31. PubMed ID: 37384807
[TBL] [Abstract][Full Text] [Related]
17. Koebnerization of Hailey-Hailey disease into a cutaneous drug eruption of acute generalized exanthematous pustulosis associated with systemic symptoms.
Totonchy MB; McNiff JM; Bunick CG
J Cutan Pathol; 2016 Nov; 43(11):1031-1035. PubMed ID: 27433827
[TBL] [Abstract][Full Text] [Related]
18. Multiple drug hypersensitivity syndrome manifesting as acute generalised exanthematous pustulosis: A rare case report.
Bragança M; Brandão Abreu D; Moço Coutinho R; Rodrigues Cernadas J; Carneiro-Leão L
Contact Dermatitis; 2024 Apr; 90(4):439-441. PubMed ID: 38234058
[No Abstract] [Full Text] [Related]
19. Recognition and Management of Severe Cutaneous Adverse Drug Reactions (Including Drug Reaction with Eosinophilia and Systemic Symptoms, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis).
Owen CE; Jones JM
Med Clin North Am; 2021 Jul; 105(4):577-597. PubMed ID: 34059239
[TBL] [Abstract][Full Text] [Related]
20. Skin tests in the work-up of cutaneous adverse drug reactions: A review and update.
Barbaud A; Castagna J; Soria A
Contact Dermatitis; 2022 May; 86(5):344-356. PubMed ID: 35122269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
